Skip to main content
. 2020 Sep 24;15(9):e0239445. doi: 10.1371/journal.pone.0239445

Table 1. Diseases and their opportunity guarantees considered in the study.

GES–OG Disease Description OG OG [days]
GES17-a Lymphomas (≥ 15y) Diagnostic confirmation to staging 30
GES17-b Lymphomas (≥ 15y) Staging to chemotherapy (1) 10
GES25 Impulse generation and driving disorders requiring a pacemaker (≥ 15y) Diagnostic confirmation to treatment 30
GES26 Preventive cholecystectomy (≥ 35y and ≤ 49y) Diagnostic confirmation to surgery 90
GES27 Gastric cancer Diagnostic confirmation to treatment 30
GES31 Diabetic retinopathy Diagnostic confirmation to treatment 60
GES32 Nontraumatic rheumatogenous retinal detachment Diagnostic confirmation to treatment 7
GES37 Ischemic stroke (≥ 15y) Diagnostic confirmation to treatment 1
GES42 Subarachnoid hemorrhage secondary to ruptured brain aneurysms Diagnostic confirmation to treatment 1
GES43 Primary tumors of the central nervous system Diagnostic confirmation to treatment 30
GES49 Moderate or severe head trauma Diagnostic confirmation to treatment 1
GES50 Severe eye trauma Diagnostic confirmation to treatment 3
GES67 Recurrent remitting multiple sclerosis Diagnostic confirmation to treatment 30
GES69 Hepatitis C Diagnostic confirmation to pre-treatment 30
GES70 Colorectal cancer (≥ 15y) Diagnostic confirmation to staging 45
GES73 Osteosarcoma (≥ 15y) Medical indication to treatment (2) 30

OG: opportunity guarantee.

GES–OG: specific opportunity guarantee for a given disease.

(1) Staging is the process through examinations and tests to learn the extent of the cancer within the body.

(2) We assume medical indication is equivalent to diagnostic confirmation.